RIL: KV Kamath appointed as independent director of Reliance, Jio Financial Services to be listed soon

-


 KV Kamath Appointed RIL Director: Reliance Industries on Friday said it has appointed KV Kamath as an independent director on its board for a period of five years. Kamath has vast experience in the banking industry and is currently the chairman of the National Bank for Financing Infrastructure and Development (NaBIFD).

 Extension Reliance Strategic Investments Limited (RSIL) has appointed KV Kamath as non-executive chairman. It has been informed by the company that the name of RSIL will also be changed to Jio Financial Services and it will be listed. KV Kamath will continue to serve as the independent director and non-executive chairman of JFSL. Reliance Industries on Friday said it has appointed KV Kamath as an independent director on its board for a period of five years. In addition, Kamath has also been appointed as an independent director and non-executive chairman of Reliance Strategic Investments Ltd., the entity that will shape the group's financial services business. The name of the company has been changed to Jio Financial Services. KV Kamath has a vast experience in the banking industry and is currently the chairman of the National Bank for Financing Infrastructure and Development (NaBIFD). He has also served as the chairman of the IT giant Infosys.

Comments

Post a Comment

Popular posts from this blog

The Role of SEBI in Regulating the Indian Stock MarketIntroduction

-
The Role of SEBI in Regulating the Indian Stock MarketIntroduction: The Securities and Exchange Board of India (SEBI) plays a vital role in overseeing and regulating the Indian stock market. Established in 1988, SEBI is the regulatory authority tasked with ensuring fair and transparent functioning of India's capital markets. In this article, we will explore the key responsibilities and functions of SEBI and understand its significance in maintaining investor confidence and market integrity. 1. Regulatory Functions of SEBI: SEBI's primary objective is to protect the interests of investors and promote the development of the securities market. The regulatory functions of SEBI include: Registration and Regulation of Market Intermediaries:  SEBI registers and regulates various market participants, such as stockbrokers, depository participants, merchant bankers, and mutual funds. It sets guidelines and codes of conduct for their operations. Regulation of Stock Exchanges: SEBI oversee...
Read full article »

How to Start Trading in the Indian Stock Market

-
 A Beginner's Guide: How to Start Trading in the Indian Stock Market Introduction The Indian stock market offers a world of opportunities for investors looking to grow their wealth. However, diving into the market without proper knowledge can be overwhelming. If you're a newcomer, fear not! This article will guide you through the essential steps to start trading in the Indian stock market. Understanding the Indian Stock Market Before you start trading, it's crucial to grasp the basics of the Indian stock market. The market is primarily divided into two major exchanges: the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE). Both exchanges facilitate the buying and selling of stocks, commodities, and derivatives. Getting Started: Open a Demat and Trading Account The first step towards stock market trading in India is to open a Demat and Trading account. A Demat account holds your securities in electronic form, while a Trading account allows you to buy and sell...
Read full article »

five analyst stock picks with over 10% revenue and profit growth in Q2FY23

-
Image
FIVE STOCK WITH 10% GROWTH This week, we take a look at five analyst stock picks with over 10% revenue and profit growth in Q2FY23 1.Solar Pharmaceutical Industries:   KRChoksey maintains its ‘purchase’ score on this pharmaceutical massive with a target charge of Rs 1,229– an upside of 19.9%. In Q2FY23, the agency’s net income grew 10.5% YoY to Rs 2,262.2 crore and revenue rose 13.8% YoY to Rs 10,952.3 crore.  Analyst Kushal Shah believes that the enterprise’s increase in Q2 was primarily pushed by using the worldwide distinctiveness business phase. In terms of geography, increase turned into led via america, India, and rising market segments, he brought. The analyst expects the organisation to retain to perform well within the US market at the back of recent launches, higher supply chain control, and market proportion profits. The company’s product pipeline in the US stays healthful with ninety two abbreviated new drug programs and thirteen new drug programs looking forward ...
Read full article »